196 related articles for article (PubMed ID: 36796518)
21. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
[No Abstract] [Full Text] [Related]
22. Recent advances and research progress in biomarkers for chronic graft versus host disease.
Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
[TBL] [Abstract][Full Text] [Related]
23. The predictive value of pulmonary function test before transplantation for chronic pulmonary graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation.
Yang L; Cheng J; Li F; Qian R; Zhang X; Jin S; He X; Xu T; Hu X; Ma X; Chen J; Zhu Y; Chen F
BMC Pulm Med; 2022 Dec; 22(1):473. PubMed ID: 36510158
[TBL] [Abstract][Full Text] [Related]
24. Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease.
Novitzky-Basso I; Schain F; Batyrbekova N; Webb T; Remberger M; Keating A; Mattsson J
PLoS One; 2023; 18(3):e0282753. PubMed ID: 36893113
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
[TBL] [Abstract][Full Text] [Related]
26. The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study.
Zhang Y; Chen X; Yang D; Pang A; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Feng S
Front Immunol; 2022; 13():1004787. PubMed ID: 36172387
[TBL] [Abstract][Full Text] [Related]
27. Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host Disease.
El Jurdi N; Herzog S; Shanley R; Holtan SG; MacMillan ML; Weisdorf DJ
Transplant Cell Ther; 2024 Jun; 30(6):616-625. PubMed ID: 38479549
[TBL] [Abstract][Full Text] [Related]
28. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia.
Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Karamlou Y; Shekarabi M; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Rezaei N
Transpl Immunol; 2023 Apr; 77():101803. PubMed ID: 36842567
[TBL] [Abstract][Full Text] [Related]
29. Association between CD34
Yao D; Li B; Chu X; Pan J; Meng L; Hu Y; Gao L; Li J; Tian Y; Hu S
Transpl Immunol; 2023 Apr; 77():101779. PubMed ID: 36596428
[TBL] [Abstract][Full Text] [Related]
30. [Analysis and Modeling of Risk Factors for Children with Intestinal Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
Li XG; Xu YF; Wang RM; Yao T; Chen F; Lang T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1516-1522. PubMed ID: 37846710
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].
Cheng XJ; Ji R; Huan RH; Huang SQ; Fan W; Zhao YC; Yuan RD; Wang XQ; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):242-248. PubMed ID: 38716595
[No Abstract] [Full Text] [Related]
32. Emergency Department Utilization Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Longitudinal Analysis of 557 Patients.
Cserna J; Baumann CK; Lobmeyr E; Grafeneder J; Ettl F; Eibensteiner F; Rabitsch W; Mitterbauer M; Knaus HA; Wohlfarth P
Transplant Cell Ther; 2023 May; 29(5):321.e1-321.e9. PubMed ID: 36842484
[TBL] [Abstract][Full Text] [Related]
33. [Recent advances in prevention and treatment of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Toubai T; Hosokawa Y
Rinsho Ketsueki; 2024; 65(5):401-411. PubMed ID: 38825520
[TBL] [Abstract][Full Text] [Related]
34. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials.
DeFilipp Z; Kim HT; Yang Z; Noonan J; Blazar BR; Lee SJ; Pavletic SZ; Cutler C
Blood Adv; 2022 Dec; 6(24):6263-6270. PubMed ID: 36083121
[TBL] [Abstract][Full Text] [Related]
35. Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scores.
Rozmus J; Levine JE; Schultz KR
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):149-154. PubMed ID: 38066854
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study.
Łacina P; Crossland RE; Wielińska J; Czyż A; Szeremet A; Ussowicz M; Wróbel T; Dickinson AM; Bogunia-Kubik K
Adv Clin Exp Med; 2023 May; 32(5):539-544. PubMed ID: 36398373
[TBL] [Abstract][Full Text] [Related]
37. Frailty in Patients with Chronic Graft-versus-Host Disease.
Rashid N; Arora M; Jurdi NE; Onstad L; Pidala JA; Flowers ME; Lee SJ
Transplant Cell Ther; 2023 Jun; 29(6):367-374. PubMed ID: 36921916
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
[TBL] [Abstract][Full Text] [Related]
39. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stromal cells ameliorate chronic GVHD by boosting thymic regeneration in a CCR9-dependent manner in mice.
Zhang X; He J; Zhao K; Liu S; Xuan L; Chen S; Xue R; Lin R; Xu J; Zhang Y; Xiang AP; Jin H; Liu Q
Blood Adv; 2023 Sep; 7(18):5359-5373. PubMed ID: 37363876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
